First-line antihypertensive therapy

Comment

L Hansson. Lancet. 2000.

. 2000 Aug 5;356(9228):508-9.

doi: 10.1016/S0140-6736(05)74179-9.

No abstract available

Comment on

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S. Hansson L, et al. Lancet. 1998 Jun 13;351(9118):1755-62. doi: 10.1016/s0140-6736(98)04311-6. Lancet. 1998. PMID: 9635947 Clinical Trial.
Are drugs within a class interchangeable?
Furberg CD, Herrington DM, Psaty BM. Furberg CD, et al. Lancet. 1999 Oct 2;354(9185):1202-4. doi: 10.1016/S0140-6736(99)03190-6. Lancet. 1999. PMID: 10513728 Review. No abstract available.
Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Messerli FH. Messerli FH. Lancet. 2000 Mar 11;355(9207):863-4. doi: 10.1016/s0140-6736(00)00092-1. Lancet. 2000. PMID: 10752699 Clinical Trial. No abstract available.